Is Lockheed Martin Entering a New Growth Cycle Through Missile Defense?

Lockheed Martin's Missiles and Fire Control segment delivered 19% year-over-year sales growth to $4.1 billion in Q2 2026 and a 24% rise in operating profit to $594 million, driven by PAC-3, THAAD and PrSM volumes. THAAD-related awards helped lift total backlog by $36.8 billion in the first half to $230.4 billion, strengthening long-term revenue visibility. Lockheed raised its 2026 MFC sales outlook to $16.5-$16.9 billion from $16.1-$16.9 billion, while consensus forecasts call for EPS growth of 31.7% in 2026 and 8.44% in 2027.

Analysis

The relevant rerating mechanism is not simply missile demand but conversion quality: a large portion of the incremental visibility is tied to an undefinitized action, which supports a production narrative before final pricing, schedule and margin terms are locked. LMT can outperform over the next 1-3 quarters if funded backlog converts into booked orders and management holds MFC margin near the implied 14% level; failure to definitize on favorable terms would make the headline backlog less valuable than the market assumes.

LMT is more directly levered than RTX or NOC to interceptor throughput, but RTX is the higher-quality second-order beneficiary if demand broadens from interceptors to integrated sensors, radars and command-and-control. NOC has longer-duration exposure through space-based and next-generation architectures, making it less sensitive to near-term production volume but better positioned for a 6-18 month shift toward layered missile-defense procurement. Suppliers of solid rocket motors and energetics—Aerojet assets within L3Harris (LHX), alongside propulsion capacity across the supply base—are the probable bottleneck; capacity constraints could preserve pricing power but also delay LMT revenue conversion.

Consensus likely overweights the apparent valuation discount and underweights execution risk: defense multiples do not expand sustainably on backlog alone when working capital, fixed-price contract mix, and appropriations timing remain uncertain. The near-term catalyst is the next earnings call’s disclosure on definitization, funded backlog, MFC margin and 2027 volume assumptions. A reversal signal would be MFC margin below ~14%, reduced interceptor delivery expectations, or a continuing resolution that delays procurement awards beyond the first quarter of the fiscal year.

Key Decisions for Investors

• Initiate a 3-6 month long LMT / short NOC pair at equal dollar exposure: LMT has the cleaner near-term earnings-revision path from production ramp, while NOC's longer-cycle programs are more exposed to award timing. Target 8-12% relative outperformance; exit if LMT's next reported MFC margin falls below 14% or funded backlog conversion weakens.
• Add RTX on pullbacks rather than chase LMT strength: use a 6-12 month position sized as a layered-defense diversification trade, with radar/sensor content offering broader program exposure. Thesis is invalidated by a defense-budget shift away from integrated air-and-missile-defense procurement or renewed supply-chain disruption in Raytheon operations.
• Monitor LHX as a supply-chain alert, not a new recommendation, for evidence that propulsion/energetics capacity is constraining deliveries. A confirmed capacity-expansion contract or improved segment margin would create a more attractive picks-and-shovels entry than prime-contractor exposure.
• Do not establish exposure to QBTS from this development; it has no demonstrated economic linkage to missile-defense production or procurement and should be excluded from the defense basket.